TransMedics Reports Revenue Growth Amid Strategic Expansion
TransMedics Group reported $189.9 million in total revenue for the second quarter of 2026, marking a 21% increase over the same period last year. Despite the growth in utilization of its Organ Care System, the company faced higher operating expenses, leading to a decline in net income compared to 2025.

























